Exemestane Shortage Update: What Patients Need to Know in 2026

If you've had trouble filling your exemestane prescription, you're not imagining it — and you're not alone. Patients across the country have reported difficulty locating exemestane at their regular pharmacies. Here is the most current information on exemestane's supply status in 2026 and what it means for your treatment.

Current FDA Shortage Status: Not Officially in Shortage

As of 2026, exemestane does NOT appear on the FDA Drug Shortages Database. The FDA requires manufacturers to notify them of anticipated supply disruptions, and no such notification has been issued for exemestane. This means there is no declared national manufacturing shortage.

However, the FDA shortage list only tells part of the story. It tracks manufacturer-level supply disruptions — not pharmacy-level stockouts. A pharmacy can run out of a medication for many reasons that never trigger an FDA shortage declaration: low order quantities, supplier contract issues, distribution delays, or simply not reordering frequently enough for a lower-volume drug.

Why Patients Are Having Trouble Filling Exemestane

Several factors contribute to the real-world difficulty patients are experiencing:

1. Exemestane is a lower-volume drug. Anastrozole and letrozole — the other two FDA-approved aromatase inhibitors — are prescribed far more frequently. Pharmacies stock exemestane in smaller quantities because fewer patients take it. When demand ticks up or a reorder is delayed, pharmacies quickly run out.

2. Multiple generic manufacturers, each with limited production. Generic exemestane is made by Alvogen, Breckenridge, Cipla, and Mylan, among others. Each has its own production schedule, and a pause by one manufacturer can create a gap for pharmacies that depend on that supplier.

3. Insurance and prior authorization delays. Some patients mistake an insurance authorization hold-up for a supply problem. If your insurance requires prior authorization for exemestane, your prescription can sit at the pharmacy for several days without being filled — even if the drug is physically in stock.

4. Post-patent market consolidation. Since Aromasin's patent expired around 2018, the generic market has matured but also consolidated — some manufacturers have dropped out because margins on lower-volume generics can be thin. Fewer active manufacturers means less redundancy in the supply chain.

Historical Shortage Context

Exemestane has not historically been a shortage drug in the way that certain other oncology medications have been. It has not appeared on the FDA's shortage list for extended periods, unlike chemotherapy agents or some injectable cancer drugs. The brand-name Aromasin is still produced by Pfizer/Pharmacia & Upjohn and remains available, though at significantly higher cost than generic equivalents.

What This Means for Your Treatment

Exemestane is a maintenance medication — meaning it's taken every day, long-term (typically 5–10 years). Missing doses is not something to take lightly. Consistent hormonal therapy is critical for preventing breast cancer recurrence. Studies show that even short interruptions in AI therapy can reduce its protective benefit.

That said, missing one or two doses while you're actively trying to resolve a supply problem is very different from stopping therapy for weeks. Contact your oncologist if you're having trouble and they can advise on the urgency of the situation in your specific case.

What You Can Do Right Now

Here are the most effective steps to take when you can't find exemestane:

1. Don't wait at one pharmacy. Availability varies dramatically between pharmacies — even on the same street. The pharmacy that's out of stock today may be your neighbor's regular refill pharmacy with no issues.
2. Use medfinder. medfinder.com contacts pharmacies near you on your behalf and texts you which ones can fill your prescription. This eliminates the time-consuming process of calling pharmacies yourself.
3. Consider mail-order. Express Scripts, CVS Caremark, and Optum Rx stock exemestane consistently and can deliver a 90-day supply to your door.
4. Ask about ordering ahead. Once you find a reliable pharmacy, talk to your insurance company about getting a 90-day supply rather than 30-day fills. This reduces how often you need to locate the drug.
5. Talk to your oncologist. If the problem persists, your oncologist may help you access it through a hospital pharmacy or, if clinically appropriate, discuss whether switching to anastrozole or letrozole is an option.

When to Be Concerned

Be proactive: don't wait until you're completely out of medication to start looking. If your exemestane supply is getting low and your regular pharmacy says they don't know when they'll restock, start reaching out to other pharmacies and your oncologist immediately. The earlier you identify a problem, the more time you have to solve it without missing doses.

The Bottom Line

Exemestane is not in a declared FDA shortage in 2026, but supply gaps at individual pharmacies are real. The drug is available nationally — it may just require searching beyond your usual pharmacy. If you continue to have trouble, read our guide on alternatives to exemestane to understand your options.